These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Building Data Infrastructure to Evaluate and Improve Quality: The National Cancer Data Base and the Commission on Cancer's Quality Improvement Programs. Shulman LN; McCabe R; Gay G; Palis B; McKellar D J Oncol Pract; 2015 May; 11(3):209-12. PubMed ID: 25901051 [No Abstract] [Full Text] [Related]
3. Health for life. Medical report card. The battle against cancer. Bain M Newsweek; 2008 Jun; 151(25):51. PubMed ID: 18711889 [No Abstract] [Full Text] [Related]
5. The future of clinical cancer research in the next millennium. Freireich EJ Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2563-70. PubMed ID: 9815657 [No Abstract] [Full Text] [Related]
6. [Advances in medical oncology]. Shi YK Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):305-10. PubMed ID: 16900620 [TBL] [Abstract][Full Text] [Related]
7. Trends in the global immuno-oncology landscape. Tang J; Pearce L; O'Donnell-Tormey J; Hubbard-Lucey VM Nat Rev Drug Discov; 2018 Nov; 17(11):783-784. PubMed ID: 30337722 [No Abstract] [Full Text] [Related]
8. From New directions in immuno-oncology. Romero D Nat Rev Clin Oncol; 2019 Nov; 16(11):660. PubMed ID: 31541198 [No Abstract] [Full Text] [Related]
9. Future shock: embracing disruption in the immunotherapy revolution. Alvarnas J Am J Manag Care; 2018 Feb; 24(2 Spec No.):SP34. PubMed ID: 29689140 [No Abstract] [Full Text] [Related]
10. Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. Petrelli NJ; Winer EP; Brahmer J; Dubey S; Smith S; Thomas C; Vahdat LT; Obel J; Vogelzang N; Markman M; Sweetenham JW; Pfister D; Kris MG; Schuchter LM; Sawaya R; Raghavan D; Ganz PA; Kramer B J Clin Oncol; 2009 Dec; 27(35):6052-69. PubMed ID: 19901123 [No Abstract] [Full Text] [Related]
11. What's new in surgery for 1991? Surgical oncology. Roth JA Bull Am Coll Surg; 1991 Jan; 76(1):30-3. PubMed ID: 10170668 [No Abstract] [Full Text] [Related]
12. Clinical development of immuno-oncology in China. Wu DW; Huang HY; Tang Y; Zhao Y; Yang ZM; Wang J; Wang SH; Yu Y; Fang Y; Fang H; Bai Y; Sun C; Fan Q; Yu AQ; Wang HL; Du CX; Chen K; Huang MD; Zhang Y; Li N; Xu BH; Sun Y; He J Lancet Oncol; 2020 Aug; 21(8):1013-1016. PubMed ID: 32758460 [No Abstract] [Full Text] [Related]
13. Immuno-Oncology in China. Lu S; Chabner BA Oncologist; 2019 Feb; 24(Suppl 1):S1-S2. PubMed ID: 30819825 [TBL] [Abstract][Full Text] [Related]
14. Progress in childhood cancer: can it be maintained? Rice MS Med J Aust; 1994 Mar; 160(6):326-31. PubMed ID: 8133814 [No Abstract] [Full Text] [Related]
15. Are we winning the war on cancer? Okon T; Schwartzberg L Am J Manag Care; 2012 Feb; 18(1 Spec No.):SP10-1. PubMed ID: 22468865 [No Abstract] [Full Text] [Related]
16. [Status and developmental prospects of oncology]. Blokhin NN Vestn Akad Med Nauk SSSR; 1982; (12):17-22. PubMed ID: 7157989 [No Abstract] [Full Text] [Related]
17. [The future of oncology has begun]. Stiefelhagen P MMW Fortschr Med; 2016 Jun; 158(12):16. PubMed ID: 27323979 [No Abstract] [Full Text] [Related]
18. Federal task force seeks standards for immunotherapy biomarker studies. Finkelstein JB J Natl Cancer Inst; 2009 May; 101(10):704-6. PubMed ID: 19436032 [No Abstract] [Full Text] [Related]